Research programme: Alzheimer's disease diagnostics - Avid Radiopharmaceuticals
Alternative Names: Tau tangle diagnostic programLatest Information Update: 04 Nov 2017
At a glance
- Originator Avid Radiopharmaceuticals; Siemens Medical Solutions
- Developer Avid Radiopharmaceuticals
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in USA
- 17 Apr 2013 Preclinical development is ongoing the USA
- 23 Mar 2010 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route) (Bayer/Avid collaboration)